About
Technology
Issues
FAQ
Links
Official Page
An Orally Administered Multitarget Tyrosine Kinase Inhibitor, SU11248, Is a Novel Potent Inhibitor of Thyroid Oncogenic RET/Papillary Thyroid Cancer Kinases
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.
